Literature DB >> 3021826

Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (Pentostam).

R E Kellum.   

Abstract

In major American textbooks of dermatology and medicine the use of intralesional sodium stibogluconate (Pentostam) in the treatment of cutaneous leishmaniasis is not mentioned. In this brief informal communication I have summarized personal experience with this effective treatment modality.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021826     DOI: 10.1016/s0190-9622(86)70214-4

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

Review 1.  Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

2.  Skin uptake, distribution, and elimination of antimony following administration of sodium stibogluconate to patients with cutaneous leishmaniasis.

Authors:  M al Jaser; A el-Yazigi; M Kojan; S L Croft
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.